Resources

  This week’s set of Homerun Slides wraps up our series on the new ADA-EASD Position Statement: Management of Hyperglycemia in T2DM. "Other Considerations" topics covered include Renal Disease, Liver Dysfunction and Hypoglycemia, and Guidelines for Glycemia, BP, & Lipid Control are also provided….

Often times there can be difficulty getting approval for the patient to use a GLP-1 analog and so the patient may miss a few days of the medication and possibly decide they don’t want to continue. I have gotten in the habit of ordering the medication from the pharmacy the …

I have been using GLP-1 analogs with my patients for the past five years and have seen many patients find reasons to stop using the medication. They complain about nausea, they complain about the cost, they say the needle hurts and they have even told me that they can’t get …

When the GLP-1 analogs first came out I was slow to start using them. As a primary care physician in a busy multi-practitioner office I was used to working with oral medications for diabetes, and only as a last resort would I put patients on basal insulin. If my patients …

History of the sodium-glucose co-transporter (SGLT) inhibitors by Erica Paul, PharmD, Graduate Intern University of Florida College of Pharmacy Back in the late 1800’s, a compound called phlorizin, found in the bark of apple trees, was isolated by French chemists. Since then it has been put to use in multiple …

San MediTech’s Dynamic Continuous Glucose Monitoring System San MediTech’s Dynamic CGMS was introduced, developed and has been approved in China.  The new CGMS system was on display at the 72nd ADA Scientific Sessions Exhibit Hall.   It has not been approved for use in the U.S.  

Daily insulin glargine injections, begun during the early stages of type 2 diabetes, neither increased nor reduced the risk of heart attacks, strokes, cancer or cardiovascular-related mortality, researchers found in the largest and longest study of its kind….

The ORIGIN study also examined whether daily insulin use in people at high risk for type 2 diabetes would prevent or slow progression of the disease….

In a modern-day clinical trial of a medicine belonging to one of the world’s oldest classes of drugs, researchers have found that a drug related to aspirin and salicylate, may be a potential treatment for people with type 2 diabetes….

Many are unable to control A1c and many develop markers of risk for cardiovascular complications….